VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s share price traded down 14.7% during mid-day trading on Wednesday . The company traded as low as C$0.15 and last traded at C$0.15. 266,015 shares changed hands during mid-day trading, a decline of 10% from the average session volume of 294,436 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Price Performance
The firm has a market capitalization of C$23.52 million, a price-to-earnings ratio of -4.48 and a beta of 0.39. The company’s 50 day moving average is C$0.10 and its 200 day moving average is C$0.13. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Samsara Stock Plunges, But Technicals Flash a Buy Signal
- Market Cap Calculator: How to Calculate Market Cap
- 3 Retail Giants React to Tariffs—What It Means for Consumers
- 3 Healthcare Dividend Stocks to Buy
- Rockwell Automation Poised to Gain From U.S. Tariffs & Onshoring
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
